Heil, Florian; Babitzki, Galina; Julien-Laferriere, Alice; Ooi, Chia-Huey; Hidalgo, Manuel; Massard, Christophe; Martinez-García, Maria; Le Tourneau, Christophe; Kockx, Mark; Gerber, Peter; Rossomanno, Simona; Krieter, Oliver; Lahr, Angelika; Wild, Norbert; Vega Harring, Suzana; Lechner, Katharina
(Elsevier, 2021)
Vanucizumab is a novel bispecific antibody inhibiting vascular endothelial growth factor (VEGF-A) and angiopoietin-2 (Ang-2) that demonstrated safety and anti-tumor activity in part I of a phase I study of 42 patients with ...
